000 01612 a2200421 4500
005 20250517214555.0
264 0 _c20181002
008 201810s 0 0 eng d
022 _a1791-2423
024 7 _a10.3892/ijo.2018.4392
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKim, Myoung Jun
245 0 0 _aOncogenic IL7R is downregulated by histone deacetylase inhibitor in esophageal squamous cell carcinoma via modulation of acetylated FOXO1.
_h[electronic resource]
260 _bInternational journal of oncology
_cJul 2018
300 _a395-403 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAcetylation
_xdrug effects
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aCarcinoma, Squamous Cell
_xdrug therapy
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aEsophageal Neoplasms
_xdrug therapy
650 0 4 _aEsophageal Squamous Cell Carcinoma
650 0 4 _aForkhead Box Protein O1
_xgenetics
650 0 4 _aGene Expression Regulation, Neoplastic
_xdrug effects
650 0 4 _aHistone Deacetylase Inhibitors
_xpharmacology
650 0 4 _aHumans
650 0 4 _aInterleukin-7 Receptor alpha Subunit
_xgenetics
650 0 4 _aPeptides, Cyclic
_xpharmacology
700 1 _aChoi, Sung Kyung
700 1 _aHong, Seong Hwi
700 1 _aEun, Jung Woo
700 1 _aNam, Suk Woo
700 1 _aHan, Jeung-Whan
700 1 _aYou, Jueng Soo
773 0 _tInternational journal of oncology
_gvol. 53
_gno. 1
_gp. 395-403
856 4 0 _uhttps://doi.org/10.3892/ijo.2018.4392
_zAvailable from publisher's website
999 _c28379706
_d28379706